Today, CellaVision announced that the company's Annual Report for 2011 is available as PDF at www.cellavision.com, and can be read via the link below.
To request a printed version, please visit the investor pages at CellaVision's website. For more information, please contact:
Yvonne Mårtensson, CEO. Phone: +46 708 33 77 82, e-mail: email@example.com
Johan Wennerholm, CFO. Phone: +46 708 33 81 68, e-mail: firstname.lastname@example.org About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses, for example of infections and serious cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2011 sales were SEK 155 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq, OMX Stockholm, Small Cap list. Read more at www.cellavision.com
. CellaVision Annual Report 2011